Generics for the Europe, Japan, Singapore and other major markets are commercialized through collaborations with business partners who are leading Generic & Innovator Companies.
| In this context USV’s business model covers the following: |
- Co-development projects wherein we develop formulations, conduct clinical trials & Bio-equivalence studies and do Regulatory fillings in collaboration with our Business partners.
- Technology transfers wherein we provide complete solutions to our Business partner.
- Out-licensing wherein we license our technology / product to our Business partner
- Offering Products Dossiers in CTD formats.
|
Our state-of-the-art manufacturing facilities along with robust Quality systems and experience in Regulatory filings and audits bolster this initiative.
|
